Webinar Series: Lung Cancer Screening in Germany - From Evidence to Implementation
Lung cancer remains one of the leading causes of cancer-related mortality worldwide. In Germany, the introduction of a national lung cancer screening…
From Images to Data and
with Data to Knowledge
Transform Medical Images Into Actionable Knowledge
Break down communication barriers and data silos with reporting and workflows solutions that turn imaging data into insights healthcare and life science teams can share and trust.
Our software portfolio provides:
Guided structured reporting solutions with AI-augmented capabilities (with third-party AI partners)
Dynamic response criteria implementation with automated compliance checks and algorithmic assessment derivation for clinical trials
Collaborative workflows and multi-source data aggregation and analysis
Advanced analytics capabilities including volumetrics, radiomics and tumor growth rate analysis
Export of high-quality, structured, FHIR-compliant datasets
If you're struggling with inconsistent imaging assessments across trial sites, complex workflow processes, or difficulty extracting meaningful insights from medical images, our software portfolio delivers a solution.
Find out how this works for your specific needs.
From Our Community
mint Lesion™ allows to efficiently conduct precise oncological treatment monitoring and communicate comprehensible reports to the clinical colleagues with a simple key stroke.
mint Lesion™ is an asset for the professionality and motivation of radiological tasks. Since the introduction of this software we have structured our evaluation procedure for clinical trials and are experiencing an effective improvement in the daily routine of oncological therapy evaluation.
mint Lesion™ knows about the partially complex subtleties of assessment criteria, which makes the assessment of lesions a lot easier compared to conventional workstations.
mint Lesion™ has become an indispensable part of our tumor boards and clinical trials. It significantly strengthens the recognition of radiology and the cooperation between imaging departments and with clinical partners.
mint Lesion™ allows for fast and adequate TNM staging and provides an excellent schematic overview of an individual patient’s disease for oncologists, surgeons, and the patients.
The mint Lesion™ COVID-19 template is a tool that helps me and my colleagues to collect all important information about the patients – both clinical and imaging data. It is detailed and ensures a comprehensive standardized report.
The Mint Medical team has worked tirelessly with Imperial College London to develop and support an entire bespoke software platform to host the NIHR funded MROC study, from patient registration to the end of study. Co-ordinating CT and multiparametric MRI images, blinded double reads, treatment plans, surgical and histopathology findings and outcomes on the MROC platform has transformed the way we can deliver image-based clinical trials and bio-banking of study data.
mint Lesion™ is an innovative tool which helps radiologists in becoming central in oncologic multidisciplinary teams.
By using mint Lesion™, we are able to generate standardized, complete and consistent oncologic reports. Not only can we describe all the important aspects of a particular tumor, but we are also storing important data in the background, which can be used for quality control and science.
Good integration in the existing IT was important to us – appropriate interfaces to RIS and PACS were implemented quickly and professionally.
mint Lesion™ is an outstanding software that facilitates cancer proforma reporting and streamlines tumor treatment response assessment. Its functionality and versatility help radiologists do a better job!
Accurate, reproducible, and standardized assessment of treatment response is of fundamental importance in oncology. A powerful yet easy to use and integrated software such as mint Lesion™ may be exactly what it takes to migrate such a capability from the world of clinical trials to everyday practice of Radiology and Oncology.
If you're struggling with inconsistent imaging assessments across trial sites, complex workflow processes, or difficulty extracting meaningful insights from medical images, our software portfolio delivers the solution.
Find out how this works for your specific needs.
Knowledge Hub
From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials
The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…
